Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: tested positive to COVID-19 but without symptoms on the first week of Jun-2022; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (tested positive to COVID-19 but without symptoms on the first week of Jun-2022) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In May 2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In June 2022, the patient experienced COVID-19 (tested positive to COVID-19 but without symptoms on the first week of Jun-2022). At the time of the report, COVID-19 (tested positive to COVID-19 but without symptoms on the first week of Jun-2022) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In June 2022, SARS-CoV-2 test: (Positive) positive.         No concomitant drug was reported. No treatment drug was reported. Company comment: This is a spontaneous case concerns female patient of unspecified age, with no medical history, who experienced the unexpected non-serious adverse events of special interest, COVID-19 (COVID-19) that occurred approximately a month after the fourth dose of mRNA-1273 vaccine in COVID-19 vaccination series. SARS-CoV-2 test was Positive approximately a months after the fourth dose of mRNA1273 vaccine. The patient had received primary series and third dose of mRNA1273 vaccine on unspecified dates. No additional information is available regarding medical history and concomitant medication received and treatment details. The event outcome was unknown. Ongoing Covid 19 pandemic could be considered as confounder to the event. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report. Event seriousness assessed as per medical judgement.   Reporter did not allow further contact; Sender's Comments: This is a spontaneous case concerns female patient of unspecified age, with no medical history, who experienced the unexpected non-serious adverse events of special interest, COVID-19 (COVID-19) that occurred approximately a month after the fourth dose of mRNA-1273 vaccine in COVID-19 vaccination series. SARS-CoV-2 test was Positive approximately a months after the fourth dose of mRNA1273 vaccine. The patient had received primary series and third dose of mRNA1273 vaccine on unspecified dates. No additional information is available regarding medical history and concomitant medication received and treatment details. The event outcome was unknown. Ongoing Covid 19 pandemic could be considered as confounder to the event. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report. Event seriousness assessed as per medical judgement.